Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 52 out of 100. Lewy body dementia

Topic: Genetics and APOE

Plain-language summary

Background Vascular dementia (VaD) is the second most common cause of dementia and exhibits substantial heterogeneity in cognitive, functional, and radiological manifestations. Despite the observed differences in clinical presentation, the factors responsible for this variability have not been clearly identified. While the apolipoprotein E ( APOE ) ε4 allele is widely known to increase the risk of Alzheimer’s disease, its contribution to the manifestation of VaD symptoms remains inadequately explored, particularly in Southeast Asian populations. This study was conducted to describe the clinical characteristics of APOE ε4 carriers with VaD and evaluate how they differ from individuals without the allele. Methods A cross-sectional approach was applied in this study to evaluate patients with VaD diagnosed according to the NINDS-AIREN criteria and Hachinski Ischemic Score. The evaluation covered cognitive function, dementia severity, and functional independence using MoCA-INA, CDR, ADL, and IADL instruments. Results were considered significant when p < 0.05. Results Sixteen patients with VaD were enrolled, including six APOE ε4 carriers and ten non-carriers. APOE ε4 carriers demonstrated significantly lower MoCA-INA scores than non-carriers (10.50 ± 5.39 vs. 18.80 ± 5.43; p = 0.010). Carriers also exhibited higher proportions of moderate-to-severe dementia, lower ADL and IADL scores, and a higher prevalence of cerebral atrophy, although these differences were not statistically significant (CDR, p = 0.263; ADL, p = 0.263; IADL, p = 0.082). Conclusions This study demonstrated that APOE4 carrier status was associated with lower MoCA-INA scores in this small VaD cohort. Differences in dementia severity, functional status, and cerebral atrophy were directionally worse among carriers but did note reach statistical difference.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Gunadi, S. G. A., Fitrah, Y. A., Soraya, G. V., Jannah, A. R., Sompa, A. W., Basri, M. I., et al. (2026). Clinical Phenotype of Apoe Ɛ4 Carriers In Patients With Vascular Dementia: A Cross-Sectional Study From Indonesia. F1000Res. https://doi.org/10.12688/f1000research.188901.1

Vancouver

Gunadi SGA, Fitrah YA, Soraya GV, Jannah AR, Sompa AW, Basri MI, et al. Clinical Phenotype of Apoe Ɛ4 Carriers In Patients With Vascular Dementia: A Cross-Sectional Study From Indonesia. F1000Res. 2026. doi:10.12688/f1000research.188901.1.

BibTeX

@article{gunadi2026-88426919,
  author  = {Gunadi, S. G. A. and Fitrah, Y. A. and Soraya, G. V. and Jannah, A. R. and Sompa, A. W. and Basri, M. I. and Limoa, L. T. and Hara, N. and others},
  title   = {{Clinical Phenotype of Apoe Ɛ4 Carriers In Patients With Vascular Dementia: A Cross-Sectional Study From Indonesia}},
  journal = {F1000Res},
  year    = {2026},
  doi     = {10.12688/f1000research.188901.1},
  url     = {https://doi.org/10.12688/f1000research.188901.1}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Study details

How this study scored 52/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record left out, no data; Study design 4 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here left out, no data; Still being cited left out, no data; Senior author's track record left out, no data; Institution's track record left out, no data; Multicenter collaboration left out, no data; Indexed in PubMed 1 of 2; Free to read 0 of 2. 30 of the 58 points it could be judged on, which is 52 of 100. Total 52 of 100.30 of the 58 points we could judge = 52 of 100

Published in a peer-reviewed journal, and it is a snapshot of people at one point in time. Scored zero for sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 30 of the 58 points we could judge it on, which is 52 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (F1000Res)
Journal's citation record — / 4 No journal record from OpenAlex — left out of this score
Study design 4 / 12 A snapshot of people at one point in time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited — / 7 No citation count (not found in OpenAlex) — left out of this score
Citations per year — / 5 No citation count or no year — left out of this score
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here — / 6 Not yet checked against this library's citation graph — left out of this score
Still being cited — / 4 No yearly citation counts — left out of this score
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multicenter collaboration — / 3 Institutions not listed — left out of this score
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Points 30 / 58 Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 30 of the 58 points we could judge it on is 52 out of 100.
Total 52 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Studies in the library that share something with this one. The line above each title says what.

Related studies in Lewy body dementia from nearby years

Also tagged “apoe2”

265 studies in the library carry the topic tag “apoe2”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 265 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Lewy body dementia

See all studies in Lewy body dementia →